IHH Healthcare Berhad (SGX:Q0F)
Singapore · Delayed Price · Currency is SGD 2.920
-0.020 (-0.68%)
At close: Feb 27, 2026
Revenue by Segment
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Hospital and Healthcare - Singapore | 6.15B | 5.58B | 4.92B | 5.03B | 3.99B | |||||
Hospital and Healthcare - Singapore Growth | 10.10% | 13.46% | -2.27% | 26.04% | -9.09% | |||||
Hospital and Healthcare - Malaysia | 4.16B | 3.69B | 3.08B | 2.73B | 2.19B | |||||
Hospital and Healthcare - Malaysia Growth | 12.73% | 19.82% | 12.94% | 24.68% | -6.17% | |||||
Hospital and Healthcare - India | 4.03B | 3.55B | 3.18B | 3.73B | 2.66B | |||||
Hospital and Healthcare - India Growth | 13.39% | 11.93% | -14.85% | 40.40% | -20.03% | |||||
Hospital and Healthcare - Greater China | 1.53B | 1.31B | 998.38M | 876.89M | 662.43M | |||||
Hospital and Healthcare - Greater China Growth | 17.06% | 30.91% | 13.85% | 32.37% | 9.56% | |||||
Hospital and Healthcare - Turkey and Europe | 7.25B | 5.97B | 4.35B | 4.35B | - | |||||
Hospital and Healthcare - Turkey and Europe Growth | 21.51% | 37.04% | 0.14% | - | - | |||||
Labs | 1.78B | 1.67B | 1.67B | - | - | |||||
Labs Growth | 6.85% | -0.15% | - | - | - | |||||
Parkway Life Real Estate Investment Trust (Plife REIT) | 414.00M | 408.00M | 376.20M | 370.69M | 367.03M | |||||
Parkway Life Real Estate Investment Trust (Plife REIT) Growth | 1.47% | 8.45% | 1.49% | 1.00% | 5.49% | |||||
Others | 1.11B | 1.50B | 1.54B | 3.96B | 395.19M | |||||
Others Growth | -25.70% | -2.98% | -61.00% | 901.73% | 124.13% | |||||
Inter-Segment Revenue | -2.16B | -2.47B | -2.39B | -4.17B | -816.94M | |||||
Unallocated MFRS129 | 116.00M | -320.00M | - | - | - | |||||
International Medical University (IMU) Health - Malaysia | - | 55.00M | 262.26M | 260.06M | 251.90M | |||||
International Medical University (IMU) Health - Malaysia Growth | - | -79.03% | 0.85% | 3.24% | -4.15% | |||||
Parkway Pantai - PPL Others | - | - | - | - | 244.66M | |||||
Parkway Pantai - PPL Others Growth | - | - | - | - | 22.11% | |||||
Acibadem Holdings - Central and Eastern Europe(CEE) | - | - | - | - | 3.46B | |||||
Acibadem Holdings - Central and Eastern Europe(CEE) Growth | - | - | - | - | -8.04% | |||||
Total | 24.38B | 20.94B | 17.99B | 17.13B | 13.40B | |||||
Total Growth | 16.47% | 16.38% | 5.00% | 27.81% | -10.11% |
Revenue by Geography
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
Greater China | 1.53B | 1.31B | 998.38M | 876.89M | 662.43M | |||||
Greater China Growth | 16.91% | 30.91% | 13.85% | 32.37% | 9.56% | |||||
Malaysia | 4.27B | 3.83B | 3.44B | 2.98B | 2.44B | |||||
Malaysia Growth | 11.29% | 11.37% | 15.34% | 22.54% | -5.96% | |||||
Japan | 147.00M | 153.00M | 149.37M | 153.03M | 154.84M | |||||
Japan Growth | -3.92% | 2.43% | -2.39% | -1.17% | 11.17% | |||||
Singapore | 6.30B | 5.75B | 5.14B | 5.03B | 3.89B | |||||
Singapore Growth | 9.71% | 11.72% | 2.18% | 29.51% | -9.37% | |||||
India | 4.71B | 4.22B | 3.87B | 3.73B | 2.66B | |||||
India Growth | 11.65% | 9.07% | 3.66% | 40.40% | -20.03% | |||||
Other Regions | 7.00M | 6.00M | - | - | 138.42M | |||||
Other Regions Growth | 16.67% | - | - | - | -30.92% | |||||
Turkey and Europe | 7.42B | 5.67B | 4.38B | 4.35B | - | |||||
Turkey and Europe Growth | 30.85% | 29.38% | 0.86% | - | - | |||||
Unallocated | - | - | 4.99M | 7.67M | 8.51M | |||||
Unallocated Growth | - | - | -34.90% | -9.82% | 109.25% | |||||
Central Eastern Europe, Middle East and North Africa (CEEMENA) | - | - | - | - | 3.46B | |||||
Central Eastern Europe, Middle East and North Africa (CEEMENA) Growth | - | - | - | - | -8.04% | |||||
Total | 24.38B | 20.94B | 17.99B | 17.13B | 13.40B | |||||
Total Growth | 16.47% | 16.38% | 5.00% | 27.81% | -10.11% |
Source: S&P Global Market Intelligence.